Ledger.Open graph →
SEC Form D · filed September 1, 2021

Voltron Therapeutics, Inc

Offering
$12.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Anthony Zook · New York, NYDirectorPaul Korner · New York, NYDirectorJames Ahern · New York, NYDirectorPatrick Gallagher · New York, NYExec · DirectorMatthew Eitner · New York, NYDirectorMatthew Duffy · New York, NYExec · DirectorTimothy Mooney · Minneapolis, MNDirectorHaseeb Malik · Minneapolis, MNExec · DirectorAneek Mamik · Minneapolis, MNDirectorMarcia Page · Minneapolis, MNDirectorIlfryn Carstairs · Minneapolis, MNExec · DirectorBradley Bauer · Minneapolis, MNDirectorGeorge M. Ager, Jr · Southampton, PADirectorRobert T. Strong · Southampton, PADirectorJames J. Clarke · Southampton, PAExec · DirectorJohn J. Augustine · Southampton, PADirectorAndrew E. Dipiero, Jr · Southampton, PADirectorKenneth R. Gant · Southampton, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗